Mergers and Acquisitions Cancer Research Cancer Treatment Covid-19 Obesity Corporate Expansion Public Companies Genetic Disorders Neuromuscular Disorders Biotechnology Sector
The deal secures antibody drug supply at Syracuse Bio Campus to support Ottimo Pharma’s path to IND submission.